By Dr. Richard Nguyen, DO, FACS, FACOS | Board-Certified Surgeon | San Jose & Los Gatos, CA
Most of the semaglutide vs tirzepatide articles online compare the two medications in the abstract. What patients in San Jose and Los Gatos actually ask me is more practical: what will each one cost me every month, what does the evidence say I can realistically expect to lose, and how do those two numbers fit together over a year of treatment? This article works through both medications from that angle, so you can walk into a consultation for medical weight loss at Lifetime Surgical already knowing the right questions to ask.
Semaglutide is a GLP-1 receptor agonist, sold as Wegovy for weight management and Ozempic for type 2 diabetes. Tirzepatide activates both the GLP-1 and GIP receptors and is sold as Zepbound for weight management and Mounjaro for diabetes. Both are once-weekly injections, both slow stomach emptying and reduce appetite, and both are FDA-approved prescription medications when dispensed as the brand-name product.
Cost only matters in relation to results, so let's start there. In the STEP 1 trial, adults without diabetes taking semaglutide 2.4 mg lost an average of about 15 percent of their body weight over 68 weeks. In SURMOUNT-1, tirzepatide at the highest 15 mg dose produced an average loss of roughly 21 percent over 72 weeks. The most useful data comes from SURMOUNT-5, the first head-to-head trial, where tirzepatide produced about 20 percent average weight loss compared with roughly 14 percent for semaglutide over 72 weeks.
Two caveats matter. First, these are trial averages: some patients lost far more, and a meaningful minority lost much less. Second, both medications were paired with lifestyle counseling in every trial, which is exactly why we do not simply hand patients a prescription. Individual results vary.
Pricing for these medications has shifted repeatedly over the last two years, so treat the figures below as a starting point and confirm current numbers at your visit. In general, there are three ways patients in Santa Clara County pay for treatment.
When a plan covers weight-management GLP-1s, the out-of-pocket cost is often a specialty-tier copay, and manufacturer savings cards can lower it further, sometimes to a modest monthly amount. The catch is that many employer plans in the Bay Area still exclude anti-obesity medications entirely, or require prior authorization documenting BMI, comorbidities, and prior weight-loss attempts. Medicare Part D has historically not covered these drugs for weight loss alone. We cover the coverage landscape in more detail in our post on whether insurance covers GLP-1 weight loss in California.
Both manufacturers now sell direct to patients at prices well below the original list prices, which were above $1,000 per month. Self-pay brand-name semaglutide and tirzepatide have generally fallen into the range of roughly $350 to $650 per month depending on dose and program, with lower starting doses at the bottom of that range. Tirzepatide at higher maintenance doses has typically cost somewhat more than semaglutide at equivalent stages of treatment.
Compounded semaglutide and tirzepatide are often advertised at lower prices. Because the FDA shortage-driven allowances for mass compounding have ended, patients should understand that compounded products are not FDA-approved, are not reviewed for safety or effectiveness, and vary in quality between pharmacies. If you are weighing this option, read our comparison of compounded GLP-1s versus brand-name Wegovy and Zepbound first.
Because tirzepatide tends to cost a little more per month but also tends to produce more weight loss, the two medications end up closer on a cost-per-result basis than the monthly price alone suggests. Consider a hypothetical 250-pound patient paying self-pay prices for one year:
These are illustrative numbers, not a price quote, and your response may be above or below the trial average. But the exercise shows why I encourage patients not to choose purely on the monthly sticker price. Individual results vary.
As a surgeon who offers both options, I want to be candid: for patients with a BMI of 40 or higher, or 35 with conditions like type 2 diabetes or sleep apnea, a one-time procedure such as the gastric sleeve may produce greater and more durable weight loss, and insurance frequently covers it. Several years of self-pay medication can exceed the cost of surgery. That does not mean surgery is right for everyone, but it belongs in the conversation.
Our medical weight loss program in San Jose and Los Gatos begins with a comprehensive evaluation, including labs and a review of your history and insurance. From there we choose a medication, manage dose escalation and side effects, and pair treatment with nutrition and activity coaching. Patients who plateau or who are better candidates for surgery have direct access to that pathway under the same roof. You can contact our office to schedule a consultation.
For many patients, yes: head-to-head data show greater average weight loss, so the cost per pound lost is often similar or lower. That said, tolerability, medical history, and insurance coverage matter as much as price. Individual results vary.
Self-pay brand-name pricing has generally ranged from roughly $350 to $650 per month depending on the drug, dose, and manufacturer program. Prices change frequently, so confirm current figures at your consultation.
It depends on your plan. Many commercial plans require prior authorization, and some exclude anti-obesity medications entirely. Coverage is more common when the medication is prescribed for type 2 diabetes. Our team can help verify your benefits.
Often, yes. Switching is common when a patient plateaus or has side effects, and it is done under medical supervision with an appropriate dose transition. Whether switching makes sense depends on your response, tolerability, and coverage.
Dr. Richard Nguyen, DO, FACS, FACOS, is a board-certified general and bariatric surgeon serving San Jose and Los Gatos, California. Fellowship-trained in minimally invasive and bariatric surgery at Vanderbilt University, he has performed more than 15,000 procedures and is nationally recognized for non-mesh and advanced hernia repair. At Lifetime Surgical he combines advanced surgical technique with personalized, patient-centered care.
Wondering which surgical procedure might be right for your condition? We're here to help you understand your treatment options and develop a personalized surgical plan. Contact our office today to schedule a consultation.
Your path to improved health may be more achievable than you think—with advanced surgical techniques leading to faster recovery, reduced complications, and a significantly enhanced quality of life.
.avif)
